Abstract:Purpose of review: Cardiovascular and renal complications among solid-organ transplant recipients are a frequent source of morbidity. Appropriate management of these complications throughout the perioperative period significantly affects long-term recipient survival. This review details the identification, management, and potential preventive strategies for perioperative cardiovascular and renal complications among solid-organ transplant recipients. Recent findings: Abdominal transplant candidates have a significantly higher prevalence of risk factors for obstructive coronary artery disease than the general population. There is no consensus on pretransplant screening for coronary artery disease or determination of perioperative risk in candidates awaiting transplantation. Limitations of noninvasive cardiac screening tests such as dobutamine stress echocardiography and myocardial perfusion scintigraphy complicate preoperative evaluation and cardiac risk stratification. Coronary angiography remains the definitive mechanism for determining the presence and severity of coronary artery disease prior to transplantation; however, the relationship between angiographically documented coronary artery disease and cardiovascular morbidity after transplantation is inconsistent. This has raised speculation that perioperative adverse cardiac events are not principally caused by obstructive coronary artery disease but other acute events related to surgical intervention and allograft function. Current data indicate coronary angiography is safe even with patients demonstrating renal insufficiency. A cardiac screening program should reflect the patient population, dynamics of the transplant program, and institutional expertise. The development of classification schemes for defining and categorizing acute kidney injury reflects the importance of preserved renal function in long-term recipient survival. The potential of serum markers as indicators of acute kidney injury has provided a foundation for understanding the global influence of surgical intervention and allograft function upon recipient survival. Summary: Meticulous attention to all aspects of the transplant process, including operative events and early allograft function, is necessary to minimize morbidity. Further research is necessary to identify mechanisms that support and improve early allograft function to optimize recipient long-term survival.

Strongyloides stercoralis infection in solid organ transplant recipients

Recent advances in understanding and managing infectious diseases in solid organ transplant recipients

A Rare Case of Disseminated Strongyloidiasis Leading to Multisystem Organ Failure Following Deceased Donor Kidney Transplantation

S3767 Strongyloides Associated Gastrointestinal Bleeding in an Immunosuppressed patient

Prevention and therapy of viral infections in patients with solid organ transplantation

Clinical approach to donor‐derived infection in solid organ transplant recipients

Clinical Characteristics and Outcomes of Endemic Mycoses after Solid Organ Transplantation: A Comprehensive Review

Impact of donor multidrug‐resistant organisms on solid organ transplant recipient outcomes

Solid organ transplant-related central nervous system infections

Approaches to safe living and diet after solid organ transplantation

Cardiovascular and renal complications in patients receiving a solid-organ transplant

Assessing the quality of antimicrobial prescribing in solid organ transplant recipients: a new frontier in antimicrobial stewardship

Monocentric, Retrospective Study on Infectious Complications within One Year after Solid-Organ Transplantation at a Belgian University Hospital

Vaccinations in Paediatric Solid Organ Transplant Candidates and Recipients

Strongyloides coinfection in COVID‐19 patients treated with corticosteroids: A systematic review

Cutaneous squamous cell carcinoma in solid organ transplant recipients: Current therapeutic and screening strategies

Clinical features of multidrug-resistant organism infections in early postoperative solid organ transplantation in a single center

Long‐term outcomes after COVID‐19 infection in transplant recipients

Impact of solid organ transplant status on outcomes of hospitalized patients with COVID‐19 infection

Herpes simplex virus infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Coccidioidomycosis Transmission Through Solid Organ Transplantation (2013–2022): A Report of the Organ Procurement and Transplantation Network ad hoc Disease Transmission Advisory Committee